턴스 파마슈티컬스, Inc.
US ˙ NasdaqGS ˙ US8808811074
이 기호는 더 이상 활성화되지 않습니다.

SecurityTERN / Terns Pharmaceuticals, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership119,806 shares
Latest Disclosed Value $ 446,876
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in TERN / Terns Pharmaceuticals, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 119,806 shares of Terns Pharmaceuticals, Inc. (US:TERN) valued at $446,876 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 119,806 shares of Terns Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $6,343,728 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Terns Pharmaceuticals EC US8808811074 119,806 0 0.00 447 35.15 0.0100
2025-05-28 2025-03-31 NP Terns Pharmaceuticals EC US8808811074 119,806 21,504 21.88 331 -39.34 0.0079
2025-02-25 2024-12-31 NP Terns Pharmaceuticals EC US8808811074 98,302 -16,486 -14.36 545 -43.16 0.0119
2024-11-26 2024-09-30 NP Terns Pharmaceuticals EC US8808811074 114,788 30,192 35.69 957 66.15 0.0181
2024-08-26 2024-06-30 NP Terns Pharmaceuticals EC US8808811074 84,596 8,036 10.50 576 14.74 0.0117
2024-05-28 2024-03-31 NP Terns Pharmaceuticals EC US8808811074 76,560 -6,809 -8.17 502 -7.21 0.0105
2024-02-26 2023-12-31 NP Terns Pharmaceuticals EC US8808811074 83,369 9,839 13.38 541 46.61 0.0115
2023-11-28 2023-09-30 NP Terns Pharmaceuticals EC US8808811074 73,530 0 0.00 370 -42.61 0.0096
2023-08-25 2023-06-30 NP Terns Pharmaceuticals EC US8808811074 73,530 73,530 643 0.0153
2022-08-25 2022-06-30 NP Terns Pharmaceuticals EC US8808811074 0 -19,690 -100.00 0 -100.00
2022-05-26 2022-03-31 NP Terns Pharmaceuticals EC US8808811074 19,690 0 0.00 58 -58.27 0.0014
2022-02-25 2021-12-31 NP Terns Pharmaceuticals EC US8808811074 19,690 7,616 63.08 139 11.20 0.0030
2021-11-24 2021-09-30 NP Terns Pharmaceuticals EC US8808811074 12,074 0 0.00 126 -15.54 0.0028
2021-08-26 2021-06-30 NP Terns Pharmaceuticals EC US8808811074 12,074 0 0.00 148 -44.15 0.0032
2021-05-27 2021-03-31 NP Terns Pharmaceuticals EC US8808811074 12,074 12,074 266 0.0060
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.